https://blog.lifesciencenation.com/2026/10/20/hot-investor-mandate-medtech-focused-vc-invests-e5-15m-in-clinical-to-commercial-stage-technologies-in-north-america-and-europe/Next Phase Newsletteren2026-10-20T16:49:25+00:00Hot Investor Mandate: Medtech-Focused VC Invests €5-15M in Clinical- to Commercial-Stage Technologies in North America and Europetechnology, health, AI, business, entrepreneurship, finance, investing, artificial-intelligencehttps://blog.lifesciencenation.com/2026/10/20/hot-investor-mandate-vc-firm-invests-from-seed-to-pre-ipo-in-novel-therapeutics-and-ai-enabled-healthcare-technologies-with-strong-ties-to-china/Next Phase Newsletteren2026-10-20T16:45:39+00:00Hot Investor Mandate: VC Firm Invests from Seed to Pre-IPO in Novel Therapeutics and AI-Enabled Healthcare Technologies, With Strong Ties to Chinatechnology, health, AI, business, entrepreneurship, finance, investing, artificial-intelligencehttps://blog.lifesciencenation.com/2026/10/20/hot-investor-mandate-global-deep-tech-vc-invests-in-healthcare-medtech-biotech-and-ai-with-southeast-asia-commercialization-support/Next Phase Newsletteren2026-10-20T16:45:21+00:00Hot Investor Mandate: Global Deep-Tech VC Invests in Healthcare, MedTech, Biotech, and AI with Southeast Asia Commercialization Supporttechnology, health, AI, business, entrepreneurship, finance, investing, artificial-intelligencehttps://blog.lifesciencenation.com/2026/10/20/hot-investor-mandate-cross-border-asia-based-vc-invests-in-life-sciences-and-healthcare-companies-with-strong-focus-on-therapeutics-and-drug-discovery-platforms/Next Phase Newsletteren2026-10-20T16:45:02+00:00Hot Investor Mandate: Cross-Border Asia-Based VC Invests in Life Sciences and Healthcare Companies, With Strong Focus on Therapeutics and Drug Discovery Platformstechnology, health, AI, business, entrepreneurship, finance, investing, artificial-intelligence